Navigation Links
Inserm announces the recipients of its 2012 prizes
Date:12/4/2012

This press release is available in French.

The 2012 Inserm prizes for medical research will be awarded at a ceremony at the Collge de France on Monday 3 December 2012. This year, the grand prize will be awarded to Philippe Sansonetti in the presence of Marisol Touraine, France's Minister of Social Affairs and Health, Genevive Fioraso, France's Minister of Higher Education and Research, and Professor Andr Syrota, Chairman and CEO of Inserm. The grand prize is awarded each year to honour a member of the scientific research community whose work has contributed to advancing knowledge of human physiology, therapeutics and health in general.

Inserm Grand Prize Philippe Sansonetti

The recipient of the 2012 Grand Prize is Professor Philippe Sansonetti, the director of the Microbial Colonisation and Invasion of Mucosa unit (Inserm Unit 786) at the Institut Pasteur in Paris, in recognition of his research on microbial infection.

Prof. Sansonetti was the first to update the genetic bases in bacteria, particularly in Shigella, which causes dysentery, and which he studied the entire sequence of steps that are required for infection.

Prof. Sansonetti coordinates, along with Pascale Cossart, the Integrative Biology of Emerging Infectious Diseases laboratory of excellence.

International Prize Ingrid Grummt

The recipient of Inserm's International Prize is Professor Ingrid Grummt of the German Cancer Research Centre of Heidelberg in recognition of her epigenetics research on the molecular mechanisms that regulate gene expression.

Honour Prize Jean-Paul Soulillou

The recipient of Inserm's Honour Prize is Professor Jean-Paul Soulillou, who heads Inserm's Lymphocyte Regulation and Tolerance team at the Centre for Transplantation and Immunology Research (Inserm Unit 1064) in Nantes,
'/>"/>

Contact: Inserm press office
presse@inserm.fr
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Page: 1 2

Related medicine news :

1. EPSRC announces new green engineering projects
2. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces Faster Weight Loss than a "No-Diet" Weight Loss Diet
3. Gabrielles Angel Foundation for Cancer Research announces 2 collaborative research grants
4. Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes
5. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
6. Plastic and Reconstructive Surgery Journal announces global expansion initiatives
7. NY-Presbyterian Hospital announces participation in trial for hard-to-treat hypertension
8. Northeasterns Barnett Institute announces formation of leading analytics company, BioAnalytix, LLC
9. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
10. CRF announces late breaking trials and first report investigations to be presented at TCT 2012
11. SfN announces winners of brain awareness video contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... the Mental Health Commission of Canada identifies ways ... that police personnel receive. , "People with mental ... community, and today,s report builds on the increasingly ... mental illnesses," says Queen,s adjunct professor Dorothy Cotton, ... area of police psychology. "This is a gap-analysis ...
(Date:8/29/2014)... New York (PRWEB) August 29, 2014 ... cardiac arrest following a series of dialysis treatments has ... alleges her death was the result of Fresenius Medical ... reports. The family’s lawsuit, which was file d in ... that the use of the products resulted in ...
(Date:8/29/2014)... team of scientists from the University of Colorado School ... process to expand production of stem cells used to ... extend beyond cancer, including treatments for inborn immunodeficiency and ... published Aug. 29 in PLOS ONE , ... Medicine and Stem Cell Biology and Taiga Biotechnologies, Inc. ...
(Date:8/29/2014)... According to the Chicago Tribune, ... next month for medical marijuana, regulators, businesses, cultivators, ... as a legalized medicine. New marijuana policies address ... to operate in accordance with local government, as ... to handle legal cannabis. , Restrictions concerning ...
(Date:8/29/2014)... City, Calif. (PRWEB) August 29, 2014 ... and customer service solutions, today announced that LiveOps has ... Muscular Dystrophy Association's (MDA) Show of Strength Telethon for ... entertainment event raises money and awareness to support MDA’s ... dystrophy, an aggressive and sometimes fatal muscle disease. This ...
Breaking Medicine News(10 mins):Health News:Report advocates improved police training 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuit News: Family Alleges Woman’s Death Following Dialysis Was Caused by GranuFlo and NaturaLyte, Bernstein Liebhard LLP Reports 4Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:Medical Marijuana Approaches Legalization in Chicago 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4
... News) -- The U.S. Food and Drug Administration announced late ... drug Cialis as a treatment for enlarged prostate. According ... clinically known as benign prostatic hyperplasia (BPH) -- is a ... estimates that "more than half of men in their 60s, ...
... , THURSDAY, Oct. 6 (HealthDay News) -- The time ... for treatment is longer for men than for women, a ... admitted for substance abuse treatment for the first time last ... they started using the substance they were primarily being treated ...
... , THURSDAY, Oct. 6 (HealthDay News) -- Technology that ... patients who were severely sickened by the H1N1 flu virus, ... their study had limitations, and they noted that debate continues ... At issue is a treatment called extracorporeal membrane oxygenation, which ...
... According to Anna R. Giuliano, Ph.D., program leader in ... colleagues in the Netherlands, earlier circumcision of males in South ... of both HIV and the human papillomavirus (HPV). Their commentary ... British medical journal The Lancet Infectious Diseases (Vol. ...
... Mozes HealthDay Reporter , THURSDAY, Oct. 6 ... are home to a significantly larger pool of elderly, ... quality/lower cost institutions, new research says. While elderly ... in the country,s 122 "best" hospitals, they make up ...
... Where you live could play a larger role in ... study by researchers from the Johns Hopkins Bloomberg School ... low-income neighborhood in Baltimore, Maryland and found that, with ... diabetes, obesity among women and use of health services ...
Cached Medicine News:Health News:FDA OKs Impotence Drug Cialis to Treat Enlarged Prostate 2Health News:Oxygenating Blood of Hospitalized H1N1 Flu Patients Saved Lives: Study 2Health News:Earlier male circumcision may help to slow rates of HIV, HPV transmission in South Africa 2Health News:More Evidence Minorities in U.S. Get Poorer Hospital Care 2Health News:More Evidence Minorities in U.S. Get Poorer Hospital Care 3Health News:Place, not race, may be a larger determinant of health disparities 2
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... Disorders Drug Pipeline Insight 2014" report to their offering. ... in US is one of the largest segments of pharmaceuticals ... alarming rate, while the available therapies were unable to meet ... in the market for CNS disorder, especially over the past ...
(Date:8/29/2014)... Corporation , a neurodiagnostics medical device company based in ... Forcht Dagi , MD, DmedSc, MPH, MBA, FACS, FRCSEd  was ... " Teo Forcht Dagi is an experienced leader with ... said Remis Bistras , President and CEO of Vittamed. ... entrepreneurial expertise to our Board." Dr. Dagi is ...
(Date:8/29/2014)... 2014 Research and Markets has ... Drugs Market 2014-2018" report to their offering. ... condition that results in demyelination, axonal transection, and neurodegeneration. ... response by the immune system, which targets neurons within ... debilitating disease in which the damage of the myelin ...
Breaking Medicine Technology:US CNS Disorders Drug Pipeline Insight 2014 2Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3
... Immunoassay Plus Control is a ... in today's busy immunoassay laboratory. ... this human serum based control ... separate control products for immunoassay ...
... The Vidiera NsD Nucleic Sample Detection ... acids, post amplification. The new platform ... by capillary electrophoresis (CE), with software features ... and flexibility. Vidiera NsD has the ...
Invacare 5 Oxygen Concentrator, 230 VAC - Intl....
... PLUS CONCENTRATOR ANALYZER Now there is one ... parameters necessary for performing concentrator checks. Introducing ... efficient and cost-effective analyzer designed with technicians ... flow rate (L-min), and patient outlet pressure ...
Medicine Products: